G Guglielmini Selected Research

Antioxidants

1/2009

Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Guglielmini Research Topics

Disease

4	Thrombosis (Thrombus) 01/2023 - 01/2009
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2012 - 01/2009
1	Brain Ischemia (Cerebral Ischemia) 01/2023
1	Myocardial Infarction 01/2023
1	Ischemia 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2009
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 05/2008
1	Thrombasthenia (Glanzmann Thrombasthenia) 05/2008
1	Pulmonary Embolism 11/2005

Drug/Important Bio-Agent (IBA)

1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2012
1	VitaminsIBA 01/2009
1	Antiphospholipid AntibodiesIBA 01/2009
1	AntioxidantsIBA 01/2009
1	Estrogens (Estrogen)FDA Link 01/2009
1	IsoantibodiesIBA 05/2008
1	ParaproteinsIBA 05/2008
1	AutoantibodiesIBA 05/2008
1	1,2,6,7,8,8a- hexahydro- beta,delta,6- trihydroxy- 2- methyl- 8- (2- methyl- 1- oxobutoxy)- 1- naphthaleneheptanoic acid 4-(nitrooxy)butyl esterIBA 11/2005
1	CollagenIBA 11/2005
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2005

Therapy/Procedure

1	Stents 01/2023
1	Therapeutics 01/2009